LIVER CANCER ADULT
Clinical trials for LIVER CANCER ADULT explained in plain language.
Never miss a new study
Get alerted when new LIVER CANCER ADULT trials appear
Sign up with your email to follow new studies for LIVER CANCER ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Glowing dye guides surgeons to precisely cut out liver cancer
Disease control Recruiting nowThis study tests a special dye that makes liver cancer cells glow during surgery, helping surgeons see exactly where the tumor is and remove it more precisely. About 30 adults with early-stage liver cancer will get the dye injected before their operation. The goal is to improve c…
Matched conditions: LIVER CANCER ADULT
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Could a blood pressure drug boost liver cancer treatment?
Disease control Recruiting nowThis study tests whether giving a short infusion of angiotensin II directly into the liver artery can help radioactive beads reach tumors better and spare healthy liver tissue during a standard treatment called radioembolization. About 15 adults with liver cancer will receive the…
Matched conditions: LIVER CANCER ADULT
Phase: PHASE2 • Sponsor: Niek Wijnen • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New radiation technique aims to zap liver tumors with precision
Disease control Recruiting nowThis study tests a precise radiation treatment for liver cancer called radiation segmentectomy. Tiny radioactive beads are injected directly into the artery feeding the tumor, delivering a high dose of radiation while sparing healthy liver tissue. The goal is to see how well this…
Matched conditions: LIVER CANCER ADULT
Sponsor: Ankara University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New T-Cell therapy targets tough liver cancers
Disease control Recruiting nowThis study tests a new treatment called ECT204 for adults with advanced liver cancer that has not responded to at least two prior therapies. The treatment uses specially engineered immune cells to attack cancer cells. The goal is to check safety and find the best dose, with early…
Matched conditions: LIVER CANCER ADULT
Phase: PHASE1, PHASE2 • Sponsor: Eureka Therapeutics Inc. • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
Digital twin could boost liver cancer therapy accuracy
Knowledge-focused Recruiting nowThis study aims to improve a liver cancer treatment called TARE, which delivers radiation directly to tumors through blood vessels. Researchers will create computer models of each patient's liver blood flow to predict where the radiation goes. The goal is to help doctors plan tre…
Matched conditions: LIVER CANCER ADULT
Sponsor: University Hospital, Ghent • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
New ultrasound tool could help doctors see how liver tumors respond to therapy
Knowledge-focused Recruiting nowThis study is testing whether a special 3D ultrasound technique can help doctors better monitor how liver tumors respond to cancer therapy. About 80 adults with untreated liver cancer will have this imaging before and during treatment. The goal is to see if the method provides us…
Matched conditions: LIVER CANCER ADULT
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC